Collaborative Stage Data Set - Revised 8/7/2013
CorpusCarcinoma
Carcinoma and Carcinosarcoma of Corpus Uteri; Uterus, NOS (excluding Placenta and Adenosarcoma, Leiomyosarcoma, and Endometrial Stromal Sarcoma (ESS))
C54.0-C54.3, C54.8-C54.9, C55.9
- DISCONTINUED SITE-SPECIFIC FACTORS: SSF7, SSF8
- M-8000-8790, 8950, 8951, 8980-8981,9700-9701
- C54.0 Isthmus uteri
- C54.1 Endometrium
- C54.2 Myometrium
- C54.3 Fundus uteri
- C54.8 Overlapping lesion of corpus uteri
- C54.9 Corpus uteri
- C55.9 Uterus, NOS
- Note 1: AJCC 7th Edition TNM staging reflects the new staging adopted by the International Federation of Gynecology and Obstetrics (FIGO) and utilizes three new staging schemas for cancer of the Corpus Uteri based on histology. This is a change from the AJCC 6th Edition TNM staging. The three new schemas are:
1. Carcinoma and carcinosarcoma
2. Leiomyosarcoma and endometrial stromal sarcoma (ESS)
3. Adenosarcoma
- Note 2: Carcinosarcoma should be staged as carcinoma.
- Note 3: This schema is for carcinoma and carcinosarcoma. When coding pay attention to the FIGO Editions and descriptions about cell and tumor types, disease extension, lymph node status and metastasis.
- Note 4: AJCC TNM values correspond to the stages accepted by the Federation Internationale de Gynecologic et d'Obstetrique (FIGO). Note that FIGO uses a single stage value which corresponds to different groupings of T, N, and M values.